AHG HealthcareBeta data

Akso Health Group

$1.21-7.84%

Price as of close on Nov 3, 2026 · Financials updated Oct 31, 2026

Basics

Sector: Healthcare
Industry: Medical Distribution
Country: China
Market cap: 1.0B USD
Enterprise value: 1.0B USD
Full-time employees: 12

Overall health

Strength: lower risk than most peers: more short-term liquidity and less debt relative to equitylower risk: more liquidity and less debt vs equity
Drawback: less profitable than most peersless profitable than peers
Drawback: growing more slowly than most peersgrowing more slowly than peers
Drawback: its shares are priced higher than most peers relative to what it earnspriced higher than peers for its earnings

Ranks #903 of 1,157 healthcare companies (bottom 23%)

See how it ranks against its peers

Worth knowing

Not profitable yet. Reported a loss over the last 12 months.
Akso Health reported a net loss over the last twelve months, so earnings-based measures can't show it as cheap.
Revenue is falling. Revenue fell 6.4% in the 12 months to March 2026 vs the 12 months before.
Akso Health's revenue fell 6.4% in the 12 months to March 2026 vs the 12 months before.

StockQuotient Score

35/ 100

Oct 5 35 → Nov 4 35

Fundamentals: Yahoo Finance, not primary filings

Valuation

Is the price right?

0/100

Weak

2/3 inputs reported · Partial data

Since last quarter: No major changeValuation also moves with the share price every day.

Why

Weaker than most peers on:

▼ Earnings yield
▼ EBITDA yield

Compare with peers

Behind the score

Sector-normalized EBITDA, earnings, and free cash flow yields.

Earnings yield-2.5%

Yahoo Finance · trailing 12 monthsNegative (a loss or cash outflow), so it counts as zero whatever the share price30% base weight · Z-score -1.00Sector median: 0.0148 · MAD: 0.0148

EBITDA yield-0.2%

Yahoo Finance · trailing 12 monthsNegative (a loss or cash outflow), so it counts as zero whatever the share price50% base weight · Z-score -1.00Sector median: 0.0401 · MAD: 0.0401

Free cash flow yieldUnavailable

Missing · left out of the score · no sector data, so not countedNot counted · remaining weights rescaledSector median: 0.0000 · MAD: 0.0000

Other data (not scored)

Book yield17.4%

Yahoo FinanceReported valueInformational · 0% composite weightSector median: 0.3716 · MAD: 0.2313

Growth

Is it growing?

23/100

Weak

2/3 inputs reported · Partial data

Since last quarter: ▼ Weaker

12-month revenue fell 6.8%

Why

Weaker than most peers on:

▼ Revenue growth
▼ 3-yr revenue

Compare with peers

Behind the score

Revenue and earnings-per-share growth over one year, and revenue growth over three years.

Earnings per share growthUnavailable

Missing · left out of the score · no sector data, so not countedNot counted · remaining weights rescaledSector median: 0.0976 · MAD: 0.2991

3-year revenue growth1.6%

SEC filings · 3 years to Mar 2026Reported value33% base weight · Z-score -0.50Sector median: 0.0584 · MAD: 0.0840

Revenue growth-6.4%

SEC filings · 12 months to Mar 2026Reported value33% base weight · Z-score -1.28Sector median: 0.0609 · MAD: 0.0974

Profitability

Does it earn well?

18/100

Weak

3/3 inputs reported · High confidence

Since last quarter: ▼ Weaker

Free cash flow turned negative over the last 12 months

Why

Weaker than most peers on:

▼ Operating margin
▼ ROA
▼ ROIC

Compare with peers

Behind the score

Return on invested capital, operating margin, and return on assets.

Operating margin-149.7%

SEC filings · 12 months to Mar 2026Reported value33% base weight · Z-score -12.88Sector median: 0.0706 · MAD: 0.1217

Return on assets-9.8%

SEC filings · 12 months to Mar 2026Reported value33% base weight · Z-score -2.14Sector median: 0.0166 · MAD: 0.0537

Return on invested capital-9.0%

SEC filings · 12 months to Mar 2026Reported value33% base weight · Z-score -1.37Sector median: 0.0471 · MAD: 0.1004

Other data (not scored)

Gross margin-0.1%

Yahoo Finance · trailing 12 monthsOutlier capped at sector 5th/95th percentileInformational · 0% composite weightSector median: 0.4697 · MAD: 0.2310

Return on equity-9.8%

Yahoo Finance · trailing 12 monthsReported valueInformational · 0% composite weightSector median: 0.0330 · MAD: 0.1225

Risk

Debt, liquidity, price swings

Lower

Lower relative risk

2/3 inputs reported · Partial data

Since last quarter: No major change

Why

Stronger than most peers on:

▲ Current ratio
▲ Debt / equity

Compare with peers

Behind the score

Relative to sector peers: 0 = lower relative risk · 1 = moderate · 2 = higher. Based on leverage, beta and liquidity.

BetaUnavailable

Missing · left out of the score · no sector data, so not countedNot counted · remaining weights rescaledSector median: 0.6250 · MAD: 0.3380

Current ratio21.77×

Yahoo FinanceOutlier capped at sector 5th/95th percentile33% base weight · Z-score 11.07Sector median: 2.5860 · MAD: 1.3850

Debt / equity0.01×

Yahoo FinanceReported value33% base weight · Z-score 1.02Sector median: 0.2215 · MAD: 0.2039

Valuation, growth and profitability scores: higher is better. Risk: 0 is lower, 2 is higher. Risk is a relative proxy, not a bankruptcy probability. Scores depend on available sector peers.

Questions investors ask about Akso Health

Is Akso Health getting weaker?: Its latest SEC filing (Jul 23, 2026) got weaker in some ways: 12-month revenue fell 6.8%; free cash flow turned negative over the last 12 months. Its overall score is unchanged at 35/100 since Oct 28, 2026.
How is Akso Health valued vs its peers?: Priced higher than most peers relative to what it earns. Valuation scores 0/100 against 1,393 healthcare peers. Earnings yield -2.5% vs a peer median of 1.5% (weaker than 100% of peers).Earnings yield -2.5% vs peers 1.5% (weaker than 100% of peers).
Is Akso Health growing?: More slowly than most of its peers. Growth scores 23/100 against 1,393 healthcare peers. Revenue growth -6.4% vs a peer median of 6.1% (weaker than 80% of peers).Revenue growth -6.4% vs peers 6.1% (weaker than 80% of peers).
How profitable is Akso Health?: Less profitable than most of its peers. Profitability scores 18/100 against 1,393 healthcare peers. Operating margin -149.7% vs a peer median of 7.1% (weaker than 89% of peers).Operating margin -149.7% vs peers 7.1% (weaker than 89% of peers).
How risky is Akso Health?: Lower risk relative to 1,393 healthcare peers, judged on debt, liquidity and share-price swings. Current ratio 21.77× vs a peer median of 2.59× (stronger than 95% of peers).Current ratio 21.77× vs peers 2.59× (stronger than 95% of peers). A relative measure, not a bankruptcy probability.

Latest filing: what changed

Quarter ended Mar 31, 2026 · filed Jul 23, 2026 · compared with the quarter ended Sep 30, 2025

Got weaker

12-month revenue fell 6.8%
Free cash flow turned negative over the last 12 months

Worth watching: Akso Health is in the bottom fifth of its sector on profitability. From 2021 to 2025, 63% of companies in that position posted a loss over the following year, against 4% for the top fifth.

	Previous quarter	Latest quarter	Change
Revenue (12 months)	14.8M USD	13.8M USD	−6.8%
Net income (12 months)	−135.7M USD	−18.7M USD	−86.2%
Operating margin	-1126.5%	-149.7%	+976.9 pts
Free cash flow (12 months)	7.2M USD	−12.8M USD	turned negative
Cash	11.1M USD	170,572 USD	−98.5%

From the company’s own SEC filings, as filed. Twelve-month figures roll forward one quarter at a time.

Financials

Fiscal years from SEC annual filings · change vs the prior year

Key ratios	FY Mar 2022	FY Mar 2023	FY Mar 2024	FY Mar 2025	FY Mar 2026	Change
Gross margin	10.1%	9.6%	5.1%	-1.9%	-0.1%	▲ 1.8 pts
Operating margin	-54.3%	-108.2%	-357.8%	-1125.4%	-149.7%	▲ 976 pts
Net margin	-280.9%	-10.3%	-391.8%	-913.4%	-135.0%	▲ 778 pts
Return on assets (ROA)	-26.8%	-6.6%	-6.7%	-62.8%	-9.8%	▲ 53 pts
Return on equity (ROE)	-137.2%	-15.6%	-6.8%	-67.8%	-10.3%	▲ 57 pts
Free cash flow margin	-143.9%	—	—	6.9%	-92.5%	▼ 99 pts
Current ratio	1.24×	1.76×	39.52×	14.20×	21.77×	▲ 53%
Quick ratio	1.09×	1.62×	39.46×	14.18×	21.74×	▲ 53%
Debt to equity	—	—	—	—	—	—
Interest coverage	-4.05×	—	—	—	—	—

AHG price history

Price history is added with the daily price update and will appear after the next one.

Similar companies

Sector leaderboards

BB Biotech AGBBZA.DE100/ 100

Arbutus Biopharma CorporationABUS97/ 100

Q32 Bio Inc.QTTB97/ 100

Bringing the fundamentals into focus…

Overall health

Strength: lower risk than most peers: more short-term liquidity and less debt relative to equitylower risk: more liquidity and less debt vs equity

Drawback: less profitable than most peersless profitable than peers

Drawback: growing more slowly than most peersgrowing more slowly than peers

Drawback: its shares are priced higher than most peers relative to what it earnspriced higher than peers for its earnings

Ranks #903 of 1,157 healthcare companies (bottom 23%)

See how it ranks against its peers

Worth knowing

Not profitable yet. Reported a loss over the last 12 months.

Akso Health reported a net loss over the last twelve months, so earnings-based measures can't show it as cheap.

Revenue is falling. Revenue fell 6.4% in the 12 months to March 2026 vs the 12 months before.

Akso Health's revenue fell 6.4% in the 12 months to March 2026 vs the 12 months before.

Questions investors ask about Akso Health

Is Akso Health getting weaker?

Its latest SEC filing (Jul 23, 2026) got weaker in some ways: 12-month revenue fell 6.8%; free cash flow turned negative over the last 12 months. Its overall score is unchanged at 35/100 since Oct 28, 2026.

How is Akso Health valued vs its peers?

Priced higher than most peers relative to what it earns. Valuation scores 0/100 against 1,393 healthcare peers. Earnings yield -2.5% vs a peer median of 1.5% (weaker than 100% of peers).Earnings yield -2.5% vs peers 1.5% (weaker than 100% of peers).

Is Akso Health growing?

More slowly than most of its peers. Growth scores 23/100 against 1,393 healthcare peers. Revenue growth -6.4% vs a peer median of 6.1% (weaker than 80% of peers).Revenue growth -6.4% vs peers 6.1% (weaker than 80% of peers).

How profitable is Akso Health?

Less profitable than most of its peers. Profitability scores 18/100 against 1,393 healthcare peers. Operating margin -149.7% vs a peer median of 7.1% (weaker than 89% of peers).Operating margin -149.7% vs peers 7.1% (weaker than 89% of peers).

How risky is Akso Health?

Lower risk relative to 1,393 healthcare peers, judged on debt, liquidity and share-price swings. Current ratio 21.77× vs a peer median of 2.59× (stronger than 95% of peers).Current ratio 21.77× vs peers 2.59× (stronger than 95% of peers). A relative measure, not a bankruptcy probability.

Previous quarter

Latest quarter

Change

Revenue (12 months)

14.8M USD

13.8M USD

−6.8%

Net income (12 months)

−135.7M USD

−18.7M USD

−86.2%

Operating margin

-1126.5%

-149.7%

+976.9 pts

Free cash flow (12 months)

7.2M USD

−12.8M USD

turned negative

Cash

11.1M USD

170,572 USD

−98.5%

Key ratios

FY Mar 2022

FY Mar 2023

FY Mar 2024

FY Mar 2025

FY Mar 2026

Change

Gross margin

10.1%

9.6%

5.1%

-1.9%

-0.1%

▲ 1.8 pts

Operating margin

-54.3%

-108.2%

-357.8%

-1125.4%

-149.7%

▲ 976 pts

Net margin

-280.9%

-10.3%

-391.8%

-913.4%

-135.0%

▲ 778 pts

Return on assets (ROA)

-26.8%

-6.6%

-6.7%

-62.8%

-9.8%

▲ 53 pts

Return on equity (ROE)

-137.2%

-15.6%

-6.8%

-67.8%

-10.3%

▲ 57 pts

Free cash flow margin

-143.9%

—

6.9%

-92.5%

▼ 99 pts

Current ratio

1.24×

1.76×

39.52×

14.20×

21.77×

▲ 53%

Quick ratio

1.09×

1.62×

39.46×

14.18×

21.74×

▲ 53%

Debt to equity

—

Interest coverage

-4.05×

—